DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sahajanand Medical Technologies Limited — Press Release

NSE 52 min ago·6 Nov 2026, 6:44 am

SMT NSE

Sahajanand Medical Technologies Limited has announced the publication of its unaudited financial results for the quarter and half-year ended September 30, 2026, in newspapers. The company has submitted a press release to the stock exchange to inform the market about this development.

This disclosure is a routine regulatory requirement that allows the company to share its interim performance data with the public. For investors, this update is crucial as it provides the first glimpse into the company's financial health and operational progress for the current fiscal year.

Investors should closely examine the reported revenue growth, profit margins, and cash flow figures in the upcoming results. Monitoring these metrics will help gauge the company's trajectory and inform any future investment decisions regarding the stock.